Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

Clinical trial NCT06666348 · RECRUITING

Trial details

NCT number: NCT06666348
Sponsor: St. Justine's Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pediatric Low-grade Glioma

Start date: 2026-01-12
Primary completion: 2030-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.